Brazil Sees US$5.5 Billion in Grassroot Pharmaceutical-Biotech
Brazil Sees US$5.5 Billion in Grassroot Pharmaceutical-Biotech
CORDOBA, ARGENTINA--April 3, 2023--Researched by Industrial Info Resources (Sugar Land, Texas)--Brazil, as the leader of the pharmaceutical market in Latin America, has more than 500 pharma projects in the Industrial Info database, totaling more than US$8 billion in investments.
Industrial Info is currently monitoring 24 pharma-biotech grassroot projects in Brazil, valued at more than US$5.5 billion.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Brazil's Bio-Manguinhos Invests More than $600 Million in Biosimilar New Fi...
- Brazil's Bio-Manguinhos Institute Constructs Grassroot Site in Rio de Janei...
- Brazil's Bio-Manguinhos Institute Still in Bidding Process for Oxford's COV...
- Brazil Plans to Produce Oxford's COVID-19 Vaccine, an Industrial Info Marke...
- México registra inversiones por 2 mil millones de dólares en el sector farm...